EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cronos Group's enterprise value is $34.59 Mil.
Cronos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $87.89 Mil. Therefore, Cronos Group's EV-to-Revenue for today is 0.39.
The historical rank and industry rank for Cronos Group's EV-to-Revenue or its related term are showing as below:
CRON'
s EV-to-Revenue Range Over the Past 10 Years
Min: -2.59 Med: 37.3 Max: 943.97
Current: 0.39
During the past 10 years, the highest EV-to-Revenue of Cronos Group was 943.97. The lowest was -2.59. And the median was 37.30.
CRON's EV-to-Revenue is ranked better than 93.76% of 1026
companies
in the Drug Manufacturers industry
Industry Median: 2.28
vs CRON: 0.39
As of today (2024-04-23), Cronos Group's stock price is $2.47.
Cronos Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.23. Therefore, Cronos Group's PS Ratio for today is 10.69.
Cronos Group EV-to-Revenue Historical Data
The historical data trend for Cronos Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cronos Group EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Cronos Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Cronos Group's EV-to-Revenue falls into.
Cronos Group's current Enterprise Value is $34.59 Mil.
Cronos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $87.89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group's share price for today is $2.47.
Cronos Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Cronos Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRON has been successfully added to your 